📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-30 17:50
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
94 announcements match the current filters (relevance ≥ 5).
Clean Max Enviro Energy Lists ₹2,500 Cr Green Debt NCDs on BSE
Clean Max Enviro Energy Solutions has listed 2,50,000 senior, secured, rated, redeemable green Non-Convertible Debentures (NCDs) on the BSE. The face value is ₹1,00,000 per debenture, aggregating to a total issuance size of ₹2,500 crore. The listing approval was received from BSE on September 29, 2026, following the allotment done on September 28, 2026. The NCDs are issued across five tranches (Series A through E) to support its renewable energy financing.
Confidence: HIGH
What changedClean Max completed the listing of ₹2,500 crore of senior secured green NCDs on the BSE across five series.
Why it mattersProvides long-term green debt funding for project execution, though it will expand the company's leverage and future interest obligations.
Total fundraise value: ₹2,500 croreTotal debentures listed: 2,50,000Face value per debenture: INR 1,00,000Listing approval date: 29 September 2026
📅 Short termNeutral procedural confirmation of NCD listing; no immediate impact on equity share trading.
📈 Long termSecures institutional capital for scaling renewable capacity, though debt service metrics will be key to monitor.
⚠ Risk flags
- Increased debt service obligations
- Coupon rates and maturity tenure details were not disclosed in the filing
Key Highlights
Listed 2,50,000 green debt securities aggregating to ₹2,500 crore on BSE
Debentures carry a face value of ₹1,00,000 each
BSE listing approval received on September 29, 2026 (Notice No. 20260929-12)
Issued across 5 series: Series A (20,000), B (40,000), C (80,700), D (61,500), and E (47,800)
👀 What to Watch
Track the deployment of the ₹2,500 crore proceeds toward renewable capex and observe the associated interest cost impact in upcoming quarterly results.
Partners with Nuvoco for 46.4 MW Wind-Solar Hybrid Project in Rajasthan
Clean Max Enviro Energy Solutions has partnered with Nuvoco Vistas to set up a 46.4 MW wind-solar hybrid project in Bhikamkhore, Rajasthan. The setup comprises 20 MW wind capacity, 26.4 MWp solar capacity, and a 2-MWh Battery Energy Storage System (BESS) under a group captive model. Once operational, the project is estimated to generate ~100 million units (MU) of clean electricity annually. The project expands CleanMax's existing operational footprint of over 525 MW in Rajasthan, complementing its 6.0 GW contracted portfolio.
Confidence: HIGH
What changedCleanMax signed a commercial partnership with Nuvoco Vistas to build and supply power from a 46.4 MW wind-solar-storage project in Rajasthan.
Why it mattersExpands CleanMax's C&I contracted revenue base and adds to its 525+ MW asset presence in Rajasthan with long-term captive power offtake.
Total project capacity: 46.4 MWWind capacity: 20 MWSolar capacity: 26.4 MWpBattery storage capacity: 2-MWhExpected annual generation: ~100 MUOperational portfolio in Rajasthan: over 525 MW
📅 Short termPositive for sentiment around CleanMax's order pipeline in the C&I space; no immediate revenue impact until project execution and commissioning.
📈 Long termStrengthens recurring annuity-style revenue via long-term power sales under group captive open access structures.
⚠ Risk flags
- Project execution and transmission connectivity risks on the STU open access network
- Capex outlay, project funding, and commissioning deadline were not disclosed
Key Highlights
Partnership covers a 46.4 MW hybrid plant comprising 20 MW wind and 26.4 MWp solar capacity
Includes a 2-MWh Battery Energy Storage System (BESS) under a group captive arrangement
Expected to generate approximately 100 million units (MU) of renewable electricity annually
Builds on CleanMax's existing operational portfolio of over 525 MW in Rajasthan
👀 What to Watch
Track commissioning timelines and commercial operation dates (COD) for the project, as financial values and project capex were not disclosed in the release.
CleanMax Raises ₹2,500 Cr via India's First C&I Green Bond Issuance
CleanMax has raised ₹2,500 crore through rated, secured, listed green Non-Convertible Debentures (NCDs) via private placement. The issuance spans five series with maturities ranging between 2 to 10 years and fixed coupons of 8.25% to 8.76%. Proceeds are slated under the Green Bond Framework to finance or refinance solar, wind, hybrid, and battery storage projects. Backed by a CRISIL AA/Stable rating, the issue was anchored by IFC, NABFID, and IIFCL alongside leading domestic financial institutions.
Confidence: HIGH
What changedCleanMax completed a ₹2,500 crore green bond issuance, marking its largest domestic bond offering with a secured lock-box structure.
Why it mattersLocks in long-term fixed-rate debt funding (up to 10 years) at competitive rates (8.25%-8.76%), diversifying capital sources beyond traditional project-level bank debt.
Total fundraise: ₹2,500 croreCoupon range: 8.25% to 8.76%Tenor range: 2 years to 10 yearsFundraise vs Q1 FY27 revenue: ~300.4% (vs ₹832.16 cr in Jun 2026)Contracted portfolio: 6.0 GW as of June 30, 2026
📅 Short termPositive sentiment from successful closure of a marquee debt issue anchored by top-tier development finance institutions at tight credit spreads.
📈 Long termSignificantly strengthens the balance sheet and access to deep domestic debt capital markets, lowering overall capital costs for executing its 6.0 GW renewable pipeline.
⚠ Risk flags
- Increased leverage on the balance sheet requiring steady operational cash flows to service debt
Key Highlights
Raised ₹2,500 crore via green debt securities across five series
Maturities range from 2 to 10 years at fixed coupons of 8.25% to 8.76%
Rated CRISIL AA/Stable on both corporate credit and NCD program
Contracted renewable portfolio stood at 6.0 GW as of June 30, 2026, with Data Centres & AI accounting for 42%
Anchored by institutional investors including IFC, NABFID, and IIFCL
👀 What to Watch
Track the deployment of funds across upcoming renewable capacity additions and monitor overall finance costs and interest coverage ratios in subsequent quarterly earnings.
CleanMax Allots ₹2,500 Cr Green Debt NCDs Across 5 Series with Coupons from 8.25% to 8.765%
Clean Max Enviro Energy Solutions Limited has approved the allotment of ₹2,500 crore in Senior, Secured, Rated, Listed Green Non-Convertible Debentures (NCDs) via private placement on September 28, 2026. The issue comprises five series (Series A to E) with tenors ranging from 24 months to 120 months. Coupon rates are structured between 8.250% (Series A) and 8.765% (Series C, D, and E), with interest payable quarterly. The NCDs are secured by project assets, SPV shares, and escrow accounts, and are proposed to be listed on BSE's Wholesale Debt Market segment.
Confidence: HIGH
What changedCleanMax allotted ₹2,500 crore worth of listed secured green NCDs across five tranches.
Why it mattersSecures long-term capital (up to 10 years) for renewable energy projects, though it adds significant quarterly interest service obligations across the consolidated balance sheet.
Total Principal Issue Size: ₹2,500 croreCoupon Series A (24m): 8.250%Coupon Series C, D, E (60-120m): 8.765%Face Value per NCD: INR 1,00,000
📅 Short termNeutral immediate impact; wholesale debt listings generally do not create retail equity volatility, but confirm closing of planned project financing.
📈 Long termProvides long-tenor, lower-cost green financing supporting renewable infrastructure deployment, but increases leverage and fixed financing cash outflows.
⚠ Risk flags
- Substantial asset encumbrance (charges on project assets, SPV shares, ISRA, and cash escrows)
- Higher debt service obligations
Key Highlights
Total principal issue size of ₹2,500 crore allotted across Series A through E
Coupons range from 8.250% for 24-month debt (Series A) to 8.765% for 60 to 120-month debt (Series C, D, E)
Tenors span 24 months (Series A maturity in Sep 2028) up to 120 months (Series D & E maturity in Sep 2036)
Received securities premium totaling ₹1.5768 crore across Series C (₹1.02 lakh) and Series E (₹1.5666 crore)
👀 What to Watch
Track the deployment of funds toward green energy generation assets and monitor quarterly interest expense impacts on net margins starting Q2/Q3 FY27.
Maharashtra GST Department Initiates Search and Seizure at Clean Science and Tech Facilities
The Maharashtra State GST Department initiated search and seizure proceedings on September 23, 2026, under Section 67 of the MGST Act, 2017. The proceedings cover Clean Science and Technology Limited's registered office in Pune and manufacturing units in Kurkumbh, Daund, along with its wholly owned subsidiary Clean Fino Chem Ltd. The company stated that it is cooperating with the authorities and providing documents, with no material impact on operations or financials at present. The monetary quantum or alleged contraventions have not yet been quantified or disclosed.
Confidence: HIGH
What changedMaharashtra GST authorities launched search and seizure operations at the company's and its subsidiary's registered office and Kurkumbh manufacturing plants.
Why it mattersWhile operations remain undisrupted currently, any adverse tax demand, penalty, or input tax credit dispute could impact cash flows or reputation depending on the finalized liability.
Initiation time: 23rd September, 2026 at 14.43 hoursFinancial impact quantified: not disclosedAlleged contravention amount: not disclosed
📅 Short termMay create sentiment overhang in the stock until the GST authorities conclude proceedings and clarify whether any formal tax demand is levied.
📈 Long termLimited, unless the investigation leads to a substantial recurring tax liability, cancellation of input tax credits, or structural governance concerns.
⚠ Risk flags
- Unquantified tax liabilities or potential penalty notices pending conclusion of GST proceedings
- Regulatory and reputational risk
Key Highlights
Search and seizure initiated on September 23, 2026, at 14:43 hours (2:43 p.m.) under Section 67 of the MGST Act, 2017.
Scope covers registered office at Magarpatta City, Pune, and manufacturing units at Kurkumbh, Daund.
Proceedings include wholly owned subsidiary Clean Fino Chem Ltd.
Company reports no material operational or financial impact at present; alleged violations remain unquantified.
👀 What to Watch
Monitor upcoming regulatory disclosures for any tax demand notices, penalties, or formal show-cause notices post the conclusion of the search.
Clean Science Infuses ₹50 Cr in Wholly Owned Subsidiary Clean Fino-Chem via Rights Issue
Clean Science and Technology Limited has subscribed to 8,36,121 equity shares of its wholly owned subsidiary, Clean Fino-Chem Limited (CFCL), on a rights basis for ₹50.00 crore. The infusion is priced at ₹598 per share (₹10 face value plus ₹588 premium) and is intended to fund CFCL's ongoing projects. CFCL's turnover has grown substantially from ₹1.92 crore in FY24 to ₹46.77 crore in FY25 and ₹166 crore in FY26. The ₹50 crore investment represents approximately 5.8% of Clean Science's TTM revenue (₹869 crore) and 3.0% of its net worth (₹1,646 crore).
Confidence: HIGH
What changedClean Science injected ₹50 crore into wholly owned subsidiary Clean Fino-Chem Limited via a rights issue.
Why it mattersCFCL is Clean Science's primary vehicle for newer chemistry expansions (including HALS); its top line has scaled rapidly to ₹166 crore in FY26, and continuous funding supports ongoing capex.
Investment amount: Rs. 50,00,00,358Shares subscribed: 8,36,121Issue price per share: Rs. 598 (Rs. 10 FV + Rs. 588 premium)CFCL FY26 Turnover: Rs. 166 CroreInvestment vs Net Worth: ~3.0%Investment vs TTM Revenue: ~5.8%
📅 Short termNeutral to mildly positive; this is an internal capital reallocation within the group, fully funded from existing balance sheet strength.
📈 Long termPositive. CFCL's steep revenue ramp from ₹1.92 cr in FY24 to ₹166 cr in FY26 indicates growing commercial execution in high-value performance chemicals.
⚠ Risk flags
- Execution and ramp-up risks associated with new specialty chemical project lines
- Related-party transaction (wholly owned subsidiary)
Key Highlights
Subscribed to 8,36,121 equity shares of Clean Fino-Chem Limited aggregating to ₹50,00,00,358 in cash
Shares issued at face value of ₹10 with a premium of ₹588 per share (issue price ₹598 per share)
Clean Fino-Chem Limited revenue expanded to ₹166 crore in FY26, up from ₹46.77 crore in FY25 and ₹1.92 crore in FY24
Proceeds will be utilized to fund ongoing project expansions in speciality chemicals
👀 What to Watch
Track the commercialization timeline and margin trajectory of CFCL's new capacities, especially the HALS portfolio ramp-up, in upcoming quarterly disclosures.
CRISIL assigns CRISIL AA/Stable rating to CleanMax; evaluates Rs 2,500 cr NCD issue
CleanMax has been assigned its first corporate credit rating of 'CRISIL AA/Stable' alongside a 'CRISIL AA/Stable' rating for Rs 2,500 crore of proposed Non-Convertible Debentures (NCDs). The high investment-grade rating will support its plans to raise up to Rs 2,500 crore in domestic bonds to optimize borrowing costs. Operationally, CleanMax reported an operational renewable capacity of 4.2 GW as of June 30, 2026, with a total contracted portfolio of 6.8 GW. The company plans to add over 1.5 GW of capacity in FY27 after achieving a record 500 MW commissioning in Q1 FY27.
Confidence: HIGH
What changedCleanMax received an inaugural corporate and NCD credit rating of 'CRISIL AA/Stable' covering up to Rs 2,500 crore of proposed bond issuance.
Why it mattersSecuring an AA investment-grade rating lowers financing costs, broadens institutional debt access, and supports CleanMax's heavy capital expenditure plan of adding >1.5 GW in FY27.
Rated NCD Amount: Rs. 2,500 croresOperational Portfolio (as of 30 June 2026): 4.2 GWTotal Contracted Portfolio: 6.8 GWTargeted Capacity Addition (FY27): over 1.5 GWCommissioned in Q1 FY27: 500 MW
📅 Short termPositive sentiment driver as the maiden AA rating validates balance sheet strength and facilitates cheaper debt raising via NCDs.
📈 Long termSignificantly strengthens long-term capital access and reduces interest costs for scaling its contracted commercial and industrial RE portfolio toward multi-gigawatt targets.
⚠ Risk flags
- Execution risks in commissioning >1.5 GW capacity in FY27
- High exposure to data centre/AI customers (42% of contracted portfolio)
- Interest rate risk on future debt issuances
Key Highlights
Assigned CRISIL AA/Stable corporate credit rating and NCD rating for Rs 2,500 crore
Company is evaluating domestic bond issuance of up to Rs 2,500 crore via NCDs for future capex
Operational renewable energy portfolio stood at 4.2 GW and total contracted portfolio reached 6.8 GW as of June 30, 2026
Targeting over 1.5 GW of new capacity addition in FY27 following record 500 MW commissioning in Q1 FY27
Data Centres & AI infrastructure clients account for 42% of contracted RE Power Sales portfolio across ~600 customers
👀 What to Watch
Track the formal board approval, pricing, and terms of the proposed Rs 2,500 crore NCD issuance, along with quarterly progress toward the >1.5 GW FY27 capacity expansion target.
CRISIL Assigns 'CRISIL AA/Stable' Rating to CleanMax for ₹2,500 Cr NCDs
CRISIL Ratings has assigned a 'CRISIL AA/Stable' rating to Clean Max Enviro Energy Solutions Limited's corporate credit and proposed ₹2,500 crore Non-Convertible Debentures (NCDs). The company plans to use ~₹1,100 crore of the NCD proceeds to refinance debt across specific SPVs and ~₹1,400 crore to fund equity contributions for ongoing capacity additions. As of June 30, 2026, CleanMax maintains 3.5 GW of operational capacity and an under-construction contracted pipeline of 2.5 GW planned for commissioning over the next 18–24 months.
Confidence: HIGH
What changedCleanMax received a high-grade investment credit rating ('CRISIL AA/Stable') for its corporate profile and planned ₹2,500 crore NCD issuance.
Why it mattersThe strong rating validates CleanMax's operational portfolio and improves borrowing costs for refinancing debt and executing its 2.5 GW expansion.
Rated NCD Amount: Rs 2,500.00 croreOperational Capacity (June 30, 2026): 3.5 GWContracted Pipeline Capacity: 2.5 GWFree Cash & Equivalents (March 31, 2026): Rs 1,202 croreNCD Amount vs Q1 FY27 Revenue: ~300%
📅 Short termThe AA rating facilitates access to institutional debt at competitive yields, aiding immediate refinancing plans.
📈 Long termSupports the company's planned capacity expansion of 1.5–2.0 GW per annum, backing long-term revenue visibility under multi-year corporate PPAs.
⚠ Risk flags
- Execution risks on the 2.5 GW contracted capacity over the next 18–24 months
- Regulatory risks relating to open access, cross-subsidy surcharges, and captive power frameworks
Key Highlights
Assigned new 'CRISIL AA/Stable' rating for ₹2,500 crore Non-Convertible Debentures and Corporate Credit
Proceeds to fund ~₹1,100 crore in SPV debt refinancing and ~₹1,400 crore for capacity expansion equity
Operational renewable portfolio stands at 3.5 GW across solar, wind, and hybrid as of June 30, 2026
Contracted pipeline of 2.5 GW to be commissioned over the next 18–24 months
Consolidated net debt to EBITDA projected at 5.5–5.7 times for fiscal 2027
👀 What to Watch
Monitor the pricing and successful issuance of the ₹2,500 crore NCDs, alongside the execution progress of the 2.5 GW under-construction pipeline.
Clean Max Approves Term Sheet to Procure 1,550 MW Wind Turbines from Envision Energy
Clean Max Enviro Energy Solutions has approved the execution of a term sheet with Envision Energy India Private Limited to procure wind turbine generators for an aggregate capacity of 1,550 MW. Under the agreement, the company will procure 310 wind turbine generators of 5 MW each along with installation supervision and commissioning support. Definitive agreements for the procurement are scheduled to be executed in seven phases concluding before December 31, 2028.
Confidence: HIGH
What changedClean Max's Risk Management Committee approved a term sheet to procure 1,550 MW of wind turbines from Envision Energy India.
Why it mattersSecures turbine equipment supply for a massive 1.55 GW wind portfolio, providing clear visibility on project execution and capacity expansion through FY29.
Total Capacity: 1,550 MWTotal WTG Units: 310Turbine Rating: 5 MW eachPhases of Execution: 7 phasesTarget Completion Date: 31 December 2028Contract Value: not disclosed
📅 Short termPositive sentiment from securing major equipment supply for renewable capacity pipeline.
📈 Long termAdds 1,550 MW of generation assets by end-2028, which will substantially scale up the company's operating revenue and clean energy output.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk across 7 phases spread until December 2028
- Commercial value and capex funding details not disclosed in the term sheet
Key Highlights
Approved procurement term sheet for 1,550 MW aggregate wind power capacity
Procuring 310 wind turbine generators (WTGs) rated at 5 MW each from Envision Energy India
Execution of definitive agreements planned across 7 phases ending before 31 December 2028
Includes supervision, technical support for installation, and commissioning services
👀 What to Watch
Track the signing of definitive phase-wise agreements and project commissionings through December 2028, along with financing announcements for the 1,550 MW capacity buildout.
Rs 55 Cr PAT and 500 MW Capacity Added in Q1 FY27; EBITDA Guidance of Rs 3,000 Cr by FY28
CleanMax reported a strong Q1 FY27 with PAT reaching Rs 55 cr, driven by doubling revenues and significant margin expansion. The company added 500 MW of capacity in the quarter, keeping it on track for its 1.5 GW annual guidance. Management provided an ambitious FY28 EBITDA target of Rs 3,000 cr, which is 2.4x the FY26 level of Rs 1,290 cr. The company maintains a dominant 35% market share in the hyperscaler segment, serving global giants like Meta, Google, and Amazon.
Confidence: HIGH
What changedThe company has provided a clear multi-year growth roadmap with specific EBITDA targets and demonstrated significant operational leverage through margin expansion.
Why it mattersCleanMax is a key beneficiary of the Data Center/AI boom in India, with 42% of its capacity serving hyperscalers; its ability to lower borrowing costs while scaling capacity is a major competitive advantage.
Q1 FY27 PAT: Rs 55 crFY28 EBITDA Guidance: Rs 3,000 crQ1 Capacity Addition: 500 MWHyperscaler Market Share: 35%Current Interest Rate: 8.4%Operational Portfolio Tariff: Rs 3.93 per unit
📅 Short termThe stock may react positively to the strong margin improvement and the robust 1.5 GW capacity addition guidance for the current fiscal year.
📈 Long termThe structural shift toward green energy for industrial and data center clients provides a long runway, especially with the company's 6.8 GW total portfolio and high repeat business (80%).
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the 2.5 GW under-construction pipeline
- Regulatory changes in state-level open access policies
Key Highlights
PAT reached Rs 55 cr in Q1 FY27, supported by a 74% YoY increase in EBITDA to Rs 494 cr
Added 500 MW of new capacity in Q1, with a total contracted portfolio now at 6.8 GW
EBITDA margins in the RE Power Sales segment improved from 76% to 84% YoY
Weighted average interest rate reduced by 100 bps from 9.4% in April 2025 to 8.4% in June 2026
Management guided for a minimum EBITDA of Rs 3,000 cr by FY28, up from Rs 1,290 cr in FY26
👀 What to Watch
Watch for the execution of the 2.5 GW under-construction pipeline and the upcoming first-ever domestic corporate bond issuance following the credit rating upgrade to AA-.
Rs 264 Cr Record Revenue: Clean Science Reports 10% YoY Growth Driven by HALS Ramp-up
Clean Science and Technology reported its highest-ever consolidated quarterly revenue of Rs 264 Cr in Q1 FY27, a 10% YoY increase. The growth was primarily driven by the HALS (Hindered Amine Light Stabilizers) segment, which now contributes 22% of total sales, up from 15% previously. The company announced a strategic collaboration with Swiss partner Geneus Chem for advanced HALS grades, targeting an additional Rs 300-350 Cr revenue over the next 3-4 years. While legacy products saw a 6% YoY volume decline due to supply chain headwinds, the subsidiary CFCL has reached operational self-sufficiency.
Confidence: HIGH
What changedThe company's subsidiary (CFCL) has transitioned from an investing phase to a monetizing phase, and the HALS business has successfully diversified into export markets.
Why it mattersThis shift reduces the company's reliance on its four legacy products and introduces higher-margin, technology-intensive chemistries that could improve overall profitability and market positioning.
Consolidated Revenue (Q1 FY27): Rs 264 CrHALS Revenue Contribution: 22%Subsidiary Investment vs Market Cap: ~10.4%HALS Volume (Q1): 1,000 tonsTarget Revenue from Swiss Partnership: Rs 300-350 Cr
📅 Short termThe record revenue and operational break-even of the subsidiary are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe structural shift toward advanced HALS and performance chemicals provides a clear path for revenue diversification and long-term growth beyond legacy phenol derivatives.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Volatility in crude-linked raw material prices
- Non-availability of shipping vessels impacting exports
- Execution risk in the new Swiss technology partnership
Key Highlights
Consolidated revenue reached a record Rs 264 Cr, representing a 10% YoY growth.
HALS segment now accounts for 22% of total sales, reducing legacy product dependence from 85% to 60%.
Strategic collaboration with Geneus Chem (Switzerland) targets Rs 300-350 Cr in additional revenue over 3-4 years.
Total capital infusion in the subsidiary stands at approximately Rs 850 Cr, which is ~10.4% of the current market cap.
HALS export mix improved to nearly 50% of segment sales, compared to being entirely domestic in the first year.
👀 What to Watch
Watch for the commercialization of Performance Chemical 2 in Q3 FY27 and the execution of the Geneus Chem partnership to see if it meets the Rs 300 Cr+ revenue target.
Rs 268 Cr Revenue in Q1 FY27; HALS Contribution Rises to 22% Amid Margin Pressure
Clean Science reported an 11% YoY growth in consolidated revenue to Rs 268 Cr for Q1 FY27, driven by the ramp-up of the HALS portfolio. However, consolidated EBITDA margins compressed to 36.5% from 41.6% YoY, primarily due to raw material costs rising to 39.7% of sales. The company invested Rs 100 Cr in its subsidiary CFCL during the quarter, representing approximately 11.3% of TTM revenue. A significant structural shift is underway as HALS now contributes 22% of sales, successfully reducing legacy product concentration from 85% to 60%.
Confidence: HIGH
What changedThe company is transitioning from a legacy-product-heavy portfolio to a more diversified specialty chemical player, with HALS becoming a major revenue driver.
Why it mattersThis diversification reduces the risk associated with price volatility in core products like MEHQ and Guaiacol, while the ongoing capex signals a focus on high-value performance chemicals to drive future growth.
Q1 FY27 Consolidated Revenue: Rs 268 CrQ1 FY27 EBITDA Margin: 36.5%Q1 Capex vs TTM Revenue: ~11.3%HALS Sales Contribution: 22%Raw Material Cost % of Sales: 39.7%
📅 Short termThe stock may face pressure due to the 510 bps YoY compression in EBITDA margins, despite the double-digit revenue growth.
📈 Long termThe structural shift toward HALS and the expansion into Europe suggest a long-term strategy to scale the business and reduce dependence on a few key molecules.
⚠ Risk flags
- Margin compression due to rising raw material costs
- Execution risk for the Performance Chemical 2 facility
- Global headwinds affecting export realizations
Key Highlights
Consolidated revenue increased 11% YoY to Rs 268 Cr in Q1 FY27
HALS segment now accounts for 22% of total sales, up from 0% in FY23
Incurred Rs 100 Cr capex in Q1 FY27 towards subsidiary Clean Fino Chem Ltd
Top 4 legacy products concentration reduced to 60% from 85% in Q4 FY23
Performance Chemical 2 facility expected to be commercialized by Q3 FY27
👀 What to Watch
Monitor the margin trajectory in upcoming quarters to see if the company can pass through higher raw material costs. Watch for the successful commercialization and ramp-up of the Performance Chemical 2 unit scheduled for Q3 FY27.
Clean Science Q1 Revenue Hits ₹268 Cr; Appoints New WTD and Expands to Netherlands
Clean Science and Technology reported a strong Q1 FY27 with revenue reaching ₹268.43 Cr, a 36% sequential increase from ₹197.13 Cr in the previous quarter. The company has appointed Mr. Krishnakumar Satyanarain Saboo, an 11-year veteran of the firm, as a Whole-time Director for a five-year term to lead operations and new projects. Furthermore, the board approved the incorporation of a wholly-owned subsidiary in the Netherlands with an initial capital of EUR 50,000 to handle European distribution. A final dividend for FY26 has been confirmed with a record date of September 5, 2026.
Confidence: HIGH
What changedThe company has transitioned a senior operational leader to the Board and initiated a direct corporate presence in Europe for distribution.
Why it mattersThe sequential revenue jump suggests a recovery in demand or successful ramp-up of the HALS portfolio. Direct European presence aims to improve realizations by reducing dependence on intermediaries.
Q1 FY27 Revenue: ₹268.43 CrQ1 FY27 PAT: ₹66.28 CrRevenue vs TTM Revenue: 30.4%Netherlands Sub Capital: EUR 50,000Dividend Record Date: 5th September 2026
📅 Short termThe stock may see positive momentum due to the sharp sequential recovery in revenue and profit compared to the March 2026 quarter.
📈 Long termThe appointment of an internal operations head to the board and international expansion support the company's long-term strategy of diversifying its product basket and global reach.
⚠ Risk flags
- Volatility in crude-linked raw material prices
- Execution risk in the new international distribution entity
Key Highlights
Q1 FY27 Revenue stood at ₹268.43 Cr, representing approximately 30% of the total TTM revenue of ₹882 Cr.
Net Profit for the quarter improved to ₹66.28 Cr, up from ₹58.12 Cr in the March 2026 quarter.
Appointment of Mr. Krishnakumar Satyanarain Saboo as Whole-time Director for 5 years (Aug 2026 - July 2031).
Incorporation of a new subsidiary in the Netherlands with an initial capital of EUR 50,000 (approx. ₹46 Lakhs).
Final dividend payment scheduled for September 30, 2026, following the AGM on September 12, 2026.
👀 What to Watch
Investors should monitor the margin sustainability as revenue scales and track the progress of the Netherlands subsidiary in improving direct sales to global accounts.
Clean Science Q1 Revenue up 21% QoQ to Rs 268 Cr; PAT down 13% as margins compress
Clean Science and Technology reported Q1 FY27 consolidated revenue of Rs 268.43 cr, a 20.8% sequential increase from Rs 222.18 cr in Q4 FY26. However, net profit declined 13.2% QoQ to Rs 50.46 cr, indicating significant margin pressure compared to the previous quarter's Rs 58.12 cr. The company is expanding its global footprint by incorporating a wholly-owned subsidiary in the Netherlands with an initial capital of EUR 50,000. Additionally, the board has appointed Mr. Krishnakumar Saboo, a veteran with 11 years at the firm, as a Whole-time Director for a 5-year term.
Confidence: HIGH
What changedClean Science reported its Q1 FY27 results, announced a new international subsidiary in the Netherlands, and elevated a senior operations head to the Board of Directors.
Why it mattersThe revenue growth suggests successful capacity utilization of new units, but the sharp decline in PAT (down 34% YoY) indicates that pricing power or raw material costs remain a challenge. The new European subsidiary signals a strategic move to handle global distribution directly.
Q1 FY27 Revenue: Rs 268.43 crQ1 FY27 PAT: Rs 50.46 crQoQ Revenue Growth: 20.8%YoY PAT Growth: -34.1%Subsidiary Capital vs TTM Revenue: ~0.05%
📅 Short termThe stock may face pressure due to the sequential and year-on-year decline in net profit despite the revenue beat. The market will likely focus on the margin contraction.
📈 Long termThe company's expansion into the Netherlands and the appointment of an operations-focused director support its long-term strategy of global distribution and manufacturing efficiency, though margin recovery is key.
⚠ Risk flags
- Significant margin compression (PAT down despite higher revenue)
- Raw material price volatility affecting realizations
- High P/E of 33.0 relative to declining profit growth
Key Highlights
Consolidated Revenue for Q1 FY27 stood at Rs 268.43 cr, showing a 22% growth over the same quarter last year (Rs 219.91 cr).
Net Profit for the quarter was Rs 50.46 cr, down 34% YoY from Rs 76.57 cr in June 2025.
Final dividend record date fixed for September 5, 2026, with payment scheduled for September 30, 2026.
New Netherlands subsidiary to be established for distribution and trading with an initial capital of EUR 50,000.
Mr. Krishnakumar Saboo appointed as Whole-time Director and Factory Occupier from August 1, 2026, to July 31, 2031.
👀 What to Watch
Investors should monitor the operating profit margin (OPM) trajectory, as the current quarter shows a disconnect between strong revenue growth and declining profitability. Watch for management commentary on raw material costs and the ramp-up of the HALS series in the upcoming AGM on September 12, 2026.
Clean Science Q1 Revenue Grows 36% QoQ to ₹268 Cr; New Netherlands Subsidiary Announced
Clean Science and Technology reported a strong sequential recovery in Q1 FY27 with consolidated revenue reaching ₹268.43 Cr, up 36% from ₹197.13 Cr in Q4 FY26. Net profit for the quarter stood at ₹50.46 Cr, though it remains lower than the ₹58.12 Cr reported in the previous quarter, suggesting margin pressure. The company is expanding its global footprint by incorporating a wholly-owned subsidiary in the Netherlands with an initial capital of EUR 50,000. Additionally, the board has appointed Mr. Krishnakumar Saboo, a company veteran of 11 years, as a Whole-time Director for a five-year term.
Confidence: HIGH
What changedThe company has reported its Q1 FY27 financial results, initiated a direct European presence via a new Netherlands subsidiary, and elevated its Group President (Operations) to the Board of Directors.
Why it mattersThe sequential revenue growth indicates a potential turnaround from the previous quarter's lows. The Netherlands subsidiary is a strategic move to increase direct sales to global accounts, potentially improving long-term realizations.
Q1 FY27 Revenue: ₹268.43 CrQ1 FY27 Net Profit: ₹50.46 CrRevenue Growth (QoQ): 36.1%Subsidiary Initial Capital: EUR 50,000Dividend Record Date: September 5, 2026
📅 Short termThe stock may see positive momentum due to the sharp sequential recovery in revenue, although the slight dip in PAT compared to Q4 FY26 might temper the enthusiasm.
📈 Long termThe company's focus on new chemistries (HALS) and direct global distribution through the new European arm supports its 25% growth target, provided it can maintain its industry-leading margins.
⚠ Risk flags
- Margin compression (PAT declined despite revenue growth)
- Volatility in crude-linked raw material prices
- Time lag in passing through cost increases
Key Highlights
Consolidated Revenue for Q1 FY27 stood at ₹268.43 Cr, a significant jump from ₹197.13 Cr in the preceding quarter.
Net Profit for the quarter reported at ₹50.46 Cr with an EPS of ₹4.75.
Incorporation of a new subsidiary in the Netherlands with an initial capital of EUR 50,000 to handle European distribution and trading.
Final dividend record date fixed for September 5, 2026, with payment scheduled for September 30, 2026.
Appointment of Mr. Krishnakumar Saboo as Whole-time Director for a 5-year tenure effective August 1, 2026.
👀 What to Watch
Investors should monitor the operating margins in upcoming quarters to see if the revenue growth translates into higher profitability. Watch for the execution of the ₹300 Cr FY26 capex plan and the ramp-up of the HALS portfolio.
Clean Science Q1 Revenue at ₹268.4 Cr; Sets Sept 5 as Dividend Record Date
Clean Science and Technology reported Q1 FY27 consolidated revenue of ₹268.43 cr and a PAT of ₹66.28 cr, showing sequential growth over the March 2026 quarter. The Board has fixed September 5, 2026, as the record date for the final dividend, with payment scheduled for September 30, 2026. Additionally, the company is expanding its global footprint by incorporating a wholly-owned subsidiary in the Netherlands with an initial capital of EUR 50,000. Mr. Krishnakumar Satyanarain Saboo has been appointed as a Whole-time Director for a five-year term to lead operations.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results, formalized dividend timelines, and initiated an international corporate structure expansion into Europe.
Why it mattersThe sequential revenue growth (₹268.4 cr vs ₹197.1 cr in Mar 2026) suggests a recovery in demand or realization; the Netherlands subsidiary indicates a strategic shift toward direct international sales and job work.
Q1 FY27 Revenue: ₹268.43 crQ1 FY27 PAT: ₹66.28 crDividend Record Date: September 5, 2026Subsidiary Initial Capital: EUR 50,000Q1 Revenue vs TTM Revenue: 30.4%
📅 Short termThe stock may react to the sequential improvement in revenue and the clarity on dividend timelines over the coming weeks.
📈 Long termThe appointment of an experienced operations head and the European expansion are structural positives, though the initial scale of the foreign subsidiary is small.
⚠ Risk flags
- Volatility in crude-linked raw material prices
- Execution risk in new international markets
Key Highlights
Consolidated Revenue for Q1 FY27 stood at ₹268.43 cr, representing approximately 30.4% of TTM revenue.
Consolidated Profit After Tax (PAT) for the quarter ended June 30, 2026, was ₹66.28 cr.
Record date for final dividend entitlement fixed for September 5, 2026.
Incorporation of a new subsidiary in the Netherlands with an initial capital infusion of EUR 50,000.
Appointment of Mr. Krishnakumar Satyanarain Saboo as Whole-time Director for a 5-year term starting August 1, 2026.
👀 What to Watch
Investors should monitor the sequential margin recovery and the progress of the Netherlands subsidiary in establishing direct global distribution channels.
Clean Science Q1 PAT at ₹61.1 Cr; Netherlands Subsidiary & New WTD Appointed
Clean Science and Technology reported a strong sequential recovery in Q1 FY27, with revenue reaching ₹268.43 cr, up ~36% from ₹197.13 cr in Q4 FY26. Net profit for the quarter stood at ₹61.11 cr, a 5.1% increase over the previous quarter. The company is expanding its global footprint by incorporating a wholly-owned subsidiary in the Netherlands with an initial capital of EUR 50,000 to handle international distribution. Additionally, the board has elevated Mr. Krishnakumar Satyanarain Saboo, a 37-year industry veteran, to Whole-time Director for a five-year term.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results, initiated the setup of a European subsidiary, and promoted its Group President (Operations) to the Board of Directors.
Why it mattersThe sharp sequential revenue growth suggests a successful ramp-up of new capacities or improved demand in specialty chemicals. The Netherlands subsidiary indicates a strategic shift toward direct global distribution to improve realizations.
Revenue (Q1 FY27): ₹268.43 crPAT (Q1 FY27): ₹61.11 crQoQ Revenue Growth: 36.2%Subsidiary Initial Capital: EUR 50,000Dividend Record Date: September 5, 2026
📅 Short termThe strong sequential revenue growth and the formalization of the dividend timeline are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe establishment of a European base and the elevation of operational leadership support the company's long-term goal of diversifying its product basket and increasing direct global sales.
⚠ Risk flags
- Volatility in crude-linked raw material prices (Phenol)
- Execution risk in the new international distribution entity
Key Highlights
Revenue for Q1 FY27 stood at ₹268.43 cr, showing a significant sequential jump from ₹197.13 cr in Q4 FY26.
Net Profit for the quarter reached ₹61.11 cr, compared to ₹58.12 cr in the preceding quarter.
Incorporation of a new subsidiary in the Netherlands with an initial capital of EUR 50,000 (approx. ₹46 lakhs) for global sales and distribution.
Appointment of Mr. Krishnakumar Satyanarain Saboo as Whole-time Director for a 5-year tenure starting August 1, 2026.
Final dividend record date confirmed as September 5, 2026, with payment scheduled for September 30, 2026.
👀 What to Watch
Investors should monitor the revenue contribution from the HALS series in upcoming quarters to see if the Q1 growth momentum is sustainable. The AGM on September 12, 2026, will be a key event for further management commentary on the European expansion strategy.
Clean Science Q1 FY27 Revenue at ₹268.4 Cr; New Netherlands Subsidiary Approved
Clean Science reported a strong start to FY27 with consolidated revenue of ₹268.43 cr, a significant sequential increase from ₹197.13 cr in Mar 2026. The company maintained healthy profitability with a PAT of ₹66.28 cr for the quarter. The board also approved the incorporation of a new wholly-owned subsidiary in the Netherlands with an initial capital of EUR 50,000 to facilitate international distribution. Additionally, operations veteran Mr. Krishnakumar Saboo has been appointed as a Whole-time Director for a five-year term.
Confidence: HIGH
What changedThe company has reported a sharp sequential revenue increase and initiated a direct corporate presence in Europe through a new subsidiary.
Why it mattersThe revenue jump indicates successful scaling of new product lines or recovery in core specialty chemicals. The Netherlands entity will likely reduce dependence on third-party distributors in the European market.
Q1 FY27 Revenue: ₹268.43 crQ1 FY27 PAT: ₹66.28 crQ1 Revenue vs TTM Revenue: 30.4%Subsidiary Initial Capital: EUR 50,000Dividend Record Date: 05.09.2026
📅 Short termThe stock may see positive sentiment due to the strong sequential revenue growth compared to the March 2026 quarter.
📈 Long termThe expansion into direct European distribution and the appointment of an operations-focused director align with the company's long-term strategy to diversify its product basket and global reach.
⚠ Risk flags
- Volatility in crude-linked raw material prices
- Execution risk in the new international distribution subsidiary
Key Highlights
Consolidated Revenue for Q1 FY27 reached ₹268.43 cr, representing approximately 30.4% of the total TTM revenue.
Net Profit for the quarter stood at ₹66.28 cr, showing recovery from the ₹58.12 cr reported in the preceding quarter.
Final dividend record date set for September 5, 2026, with payment scheduled by September 30, 2026.
New European subsidiary to be incorporated in the Netherlands with an initial capital infusion of EUR 50,000.
Appointment of Mr. Krishnakumar Saboo (37+ years experience) as Whole-time Director effective August 1, 2026.
👀 What to Watch
Investors should monitor the revenue contribution from the HALS series and the efficiency of the new Netherlands subsidiary in expanding global market share. The sequential growth in revenue suggests improved utilization of Unit 4 capacities.
Clean Science Signs 5-Year Strategic Supply Deal with Kemin Industries
Clean Science and Technology Limited (CSTL) has entered into a long-term strategic supply arrangement with Kemin Industries for the food and feed sector. Under this 5-year agreement, CSTL will act as a substantial primary supplier of key ingredients, likely leveraging its leadership in products like BHA. This move aligns with the company's strategy to diversify its product basket and increase direct sales to global accounts. While the specific contract value is not disclosed, it provides revenue visibility following a period where TTM revenue declined to ₹882 Cr from ₹929 Cr in FY25.
Confidence: MEDIUM
What changedCSTL has transitioned from transactional sales to a formal, 5-year primary supplier relationship with a major global player in the food and feed industry.
Why it mattersThis partnership provides long-term volume security and validates CSTL's competitive position in specialty ingredients, helping to mitigate the impact of volatile realizations seen in its core MEHQ business.
Initial Contract Term: 5 yearsTTM Revenue: ₹882 CrFY26 Planned Capex: ₹300 CrOperating Profit Margin (TTM): 39.4%Contract Value: not disclosed
📅 Short termThe announcement is likely to be viewed positively by the market as it demonstrates business development momentum despite recent stock underperformance.
📈 Long termStructurally significant as it secures a long-term off-take partner, supporting the company's 25% targeted growth rate and diversification away from core phenol-linked products.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Contract value and volume commitments not disclosed
- Potential margin pressure if raw material (Phenol) price pass-through lags
- Client concentration risk within the food/feed segment
Key Highlights
Initial contract term of 5 years established for long-term supply.
Designated as a 'substantial primary supplier' for Kemin Industries' food and feed business.
Supports the company's FY26 growth strategy involving ₹300 Cr in greenfield capex.
Aims to stabilize revenue after a 12-month price return of -39.2% and declining annual revenue.
Leverages existing 'Clean Technology' moat to serve global specialty chemical markets.
👀 What to Watch
Investors should monitor upcoming quarterly results for commentary on the volume commitments and margin profile of this contract. The key metric to watch is the utilization rate of the new HALS and performance chemical capacities funded by the ₹300 Cr FY26 capex.
0.53 GW Commissioned in Q1; CleanMax Targets ₹3,000 Cr EBITDA by FY28
CleanMax reported its largest-ever quarterly commissioning of 0.53 GW in Q1 FY27, exceeding the 0.42 GW commissioned during the entire FY25. The company is on track to meet its 1.5 GW annual capacity addition guidance, having already achieved 40% of its STU/Onsite target in three months. A significant pivot toward Data & AI customers now accounts for 42% (2.5 GW) of the total 6 GW contracted capacity. Management has issued a forward guidance of minimum ₹3,000 Cr EBITDA for FY 2027-28, supported by a reduced cost of debt at 8.4%.
Confidence: HIGH
What changedCleanMax has transitioned from annual-scale commissioning to quarterly-scale execution, while simultaneously shifting its portfolio heavily toward high-demand Data & AI customers.
Why it mattersThe company is scaling rapidly to meet India's projected tripling of data center capacity by 2030, which requires massive renewable energy and storage infrastructure.
Q1 Commissioned Capacity: 0.53 GWTotal Contracted Capacity: 6,003 MWFY28 EBITDA Guidance: ₹3,000 CrCost of Project Debt: 8.4%Data & AI Portfolio Share: 42%FY27 Capacity Addition Target: 1.5 GW
📅 Short termPositive sentiment expected as the company is ahead of its 'run-rate' for FY27 capacity targets and has secured 100% land for remaining contracted capacity.
📈 Long termStructural growth is tied to the ₹40,000 crore renewable capex opportunity per GW of data center load, where CleanMax holds a 35%+ market share in recent hyperscaler deals.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for large-scale CTU projects in H2
- High steady-state Net Debt/EBITDA target of 5x to 5.5x
- Regulatory risks associated with STU connected group captive plants across 7 states
Key Highlights
Commissioned 0.53 GW in Q1 FY27, surpassing the 0.42 GW commissioned in the full year of FY25
Total contracted RE power sales capacity reached 6,003 MW (6 GW) as of June 30, 2026
Data & AI contracted capacity grew 10x from 0.24 GW in March 2024 to 2.5 GW in June 2026
Weighted average cost of project borrowing reduced from 9.2% to 8.4% over the last 15 months
Management provided a minimum EBITDA guidance of ₹3,000 Cr for FY 2027-28
👀 What to Watch
Watch for the execution of the 534 MW CTU-connected project in Karnataka scheduled for H2 FY27 and the maintenance of the Net Debt/EBITDA ratio within the 5x-5.5x target range.
